[HTML][HTML] Tirzepatide: A systematic update

I Forzano, F Varzideh, R Avvisato… - International Journal of …, 2022 - mdpi.com
Tirzepatide is a new molecule capable of controlling glucose blood levels by combining the
dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like …

[HTML][HTML] Nephroprotective Properties of antidiabetic drugs

C Gerdes, N Müller, G Wolf, M Busch - Journal of Clinical Medicine, 2023 - mdpi.com
Chronic kidney disease (CKD) is associated with increased morbidity and mortality,
especially from cardiovascular (CV) causes, and especially in people with diabetes mellitus …

[HTML][HTML] GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes

SS Wilbon, MG Kolonin - Cells, 2023 - mdpi.com
Glucagon-like peptide-1 receptor agonists (GLP1RA) have been transformative for patients
and clinicians in treating type-2 diabetes and obesity. Drugs of this class, the bioavailability …

The potential role of Tirzepatide as adjuvant therapy in countering colistin-induced nephro and neurotoxicity in rats via modulation of PI3K/p-Akt/GSK3-β/NF-kB p65 …

NF Hassan, D Ragab, SG Ibrahim… - International …, 2024 - Elsevier
Although colistin has a crucial antibacterial activity in treating multidrug-resistant gram-
negative bacteria strains; it exhibited renal and neuronal toxicities rendering its use a …

[HTML][HTML] Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication

JAO Nery Neto, VY Yariwake, NOS Câmara… - Frontiers in …, 2023 - frontiersin.org
Recent studies suggest that disruptions in intestinal homeostasis, such as changes in gut
microbiota composition, infection, and inflammatory-related gut diseases, can be associated …

Tirzepatide and exercise training in obesity

B Bagherzadeh-Rahmani, E Marzetti… - Clinical …, 2024 - content.iospress.com
OBJECTIVES: The purpose of this study was to investigate the effects of 6 weeks of
resistance training (RT) combined with aerobic training (AT) and Tirzepatide …

Effektive antidiabetische Therapie zur Vorbeugung einer diabetischen Nephropathie

N Müller, M Busch, C Gerdes, G Wolf - Nephrologie aktuell, 2023 - thieme-connect.com
Die chronische Nierenkrankheit (CKD:„chronic kidney disease “) stellt eine der häufigsten
Folgekomplikationen bei Menschen mit Diabetes mellitus dar und erhöht exzessiv die …

[PDF][PDF] Αξιολόγηση της επίδρασης της τιρζεπατίδης στα νεφρικά εκβάματα σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 και διαβητική νεφρική νόσο (RENT-DKD) …

ΑΓ Καραγιαννίδης - 2023 - ir.lib.uth.gr
Η παρούσα διπλωματική εργασία εκπονήθηκε στα πλαίσια του Προγράμματος
Μεταπτυχιακών Σπουδών (ΠΜΣ)«Μεθοδολογία Βιοϊατρικής Έρευνας, Βιοστατιστική και …

Noi strategii terapeutice în boala renală diabetică|[Novel therapeutic strategies in diabetic kidney disease]

L Gîrdan, CM Gavriș, L Nedelcu - Jurnal Medical Brasovean, 2024 - webbut.unitbv.ro
Introduction: Despite recent developments in therapeutic strategies that limit diabetic kidney
disease (DKD) progression, with sodium-glucose cotransporter-2 inhibitors (SGLT2i) added …

[PDF][PDF] NOI STRATEGII TERAPEUTICE ÎN BOALA RENALĂ DIABETICĂ.

L Gîrdan, CM Gavriș, L Nedelcu - Brasov Medical Journal/Jurnal …, 2023 - webbut.unitbv.ro
Introduction: Despite recent developments in therapeutic strategies that limit diabetic kidney
disease (DKD) progression, with sodium glucose cotransporter-2 inhibitors (SGLT2i) added …